Bio Techne Corp Stock Return On Equity
TE1 Stock | 71.50 0.50 0.69% |
Bio Techne Corp fundamentals help investors to digest information that contributes to Bio-Techne Corp's financial success or failures. It also enables traders to predict the movement of Bio-Techne Stock. The fundamental analysis module provides a way to measure Bio-Techne Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bio-Techne Corp stock.
Bio-Techne |
Bio Techne Corp Company Return On Equity Analysis
Bio-Techne Corp's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition |
Based on the latest financial disclosure, Bio Techne Corp has a Return On Equity of 0.0. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Return On Equity (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Bio-Techne Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bio-Techne Corp's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bio-Techne Corp could also be used in its relative valuation, which is a method of valuing Bio-Techne Corp by comparing valuation metrics of similar companies.Bio Techne is currently under evaluation in return on equity category among its peers.
Bio-Techne Fundamentals
Current Valuation | 13.06 B | |||
Price To Book | 7.56 X | |||
Price To Sales | 12.34 X | |||
Revenue | 1.11 B | |||
EBITDA | 413.76 M | |||
Net Income | 272.05 M | |||
Total Debt | 243.41 M | |||
Cash Flow From Operations | 325.27 M | |||
Price To Earnings To Growth | 1.11 X | |||
Market Capitalization | 16.22 B | |||
Total Asset | 2.29 B | |||
Z Score | 39.6 | |||
Annual Yield | 0.01 % | |||
Net Asset | 2.29 B |
About Bio-Techne Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bio Techne Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio-Techne Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Techne Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Bio-Techne Stock Analysis
When running Bio-Techne Corp's price analysis, check to measure Bio-Techne Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio-Techne Corp is operating at the current time. Most of Bio-Techne Corp's value examination focuses on studying past and present price action to predict the probability of Bio-Techne Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio-Techne Corp's price. Additionally, you may evaluate how the addition of Bio-Techne Corp to your portfolios can decrease your overall portfolio volatility.